Marvels in Medicine: Gabriel Hortobagyi on Challenging Historical Dogmas in Breast Cancer

In our exclusive interview, Gabriel N. Hortobagyi, MD, of The University of Texas MD Anderson Cancer Center shares his journey in the development of anthracyclines and taxanes, biphosphonates, and gene therapies in breast cancer, some of the challenges he has encountered along the way and what he hopes to tackle in the rest of his monumental career.